These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 14765332)
21. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. Rapezzi C; Ciliberti P; Graziosi M; Riva L Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516 [TBL] [Abstract][Full Text] [Related]
22. Is there a role for supplemented antioxidants in the prevention of atherosclerosis? Katsiki N; Manes C Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058 [TBL] [Abstract][Full Text] [Related]
23. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Carey KM; Comee MR; Donovan JL; Kanaan AO Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437 [TBL] [Abstract][Full Text] [Related]
24. [Antioxidant vitamins - importance for cardiopulmonary prophylaxis. Part II. Antioxidant food supplies - vitamin C and beta-carotene; current experience in antioxidant vitamin usage]. Andreeva-Gateva P Vutr Boles; 2000; 32(4):5-12. PubMed ID: 11688331 [TBL] [Abstract][Full Text] [Related]
25. Vitamins, antioxidants and endothelial function in coronary artery disease. Hornig B Cardiovasc Drugs Ther; 2002 Sep; 16(5):401-9. PubMed ID: 12652109 [No Abstract] [Full Text] [Related]
26. [Vitamin E for prevention of arteriosclerosis, coronary heart disease and cancer. Antioxidants--what is their value? Minerals, Vitamins & Co. Series, 6: Beta-carotene, vitamin C and E]. Pannewig K Fortschr Med; 1998 Oct; 116(29):61-2. PubMed ID: 9846478 [No Abstract] [Full Text] [Related]
27. [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients]. Belluzzi F; Sernesi L; Centola M; Perlini S Recenti Prog Med; 2009 Nov; 100(11):508-11. PubMed ID: 20066882 [TBL] [Abstract][Full Text] [Related]
28. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005]. Traut V Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292 [No Abstract] [Full Text] [Related]
29. Carotenoids and vitamins C and E in the prevention of cardiovascular disease. Riccioni G; D'Orazio N; Salvatore C; Franceschelli S; Pesce M; Speranza L Int J Vitam Nutr Res; 2012 Feb; 82(1):15-26. PubMed ID: 22811373 [TBL] [Abstract][Full Text] [Related]
30. [Oxidative stress, diseases and antioxidant treatment]. Elejalde Guerra JI An Med Interna; 2001 Jun; 18(6):326-35. PubMed ID: 11503582 [TBL] [Abstract][Full Text] [Related]
31. ACE inhibitor reduces cardiovascular events by 22%. Indian J Med Sci; 2000 Mar; 54(3):112-4. PubMed ID: 11227615 [No Abstract] [Full Text] [Related]
32. [Antioxidants in complex therapy of atherosclerosis: pro et contra]. Lankin VZ; Tikhaze AK; Belenkov IuN Kardiologiia; 2004; 44(2):72-81. PubMed ID: 15029140 [TBL] [Abstract][Full Text] [Related]
33. [Primary nutritional and drug prevention of atherosclerosis]. Monnier L; Avignon A; Colette C; Piperno M Rev Med Interne; 1999 Aug; 20 Suppl 3():360s-370s. PubMed ID: 10480187 [TBL] [Abstract][Full Text] [Related]
34. Emerging approaches in the prevention of atherosclerotic cardiovascular diseases. Lonn EM; Yusuf S Int J Clin Pract Suppl; 1998 May; 94():7-19. PubMed ID: 9926440 [TBL] [Abstract][Full Text] [Related]
35. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Marchioli R Pharmacol Res; 1999 Sep; 40(3):227-38. PubMed ID: 10479466 [TBL] [Abstract][Full Text] [Related]
36. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Sesso HD; Buring JE; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Glynn RJ; Gaziano JM JAMA; 2008 Nov; 300(18):2123-33. PubMed ID: 18997197 [TBL] [Abstract][Full Text] [Related]
37. [Experiences with the realisation of innovative study designs using the example of the HOPE-study]. Rangoonwala B Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S82-5. PubMed ID: 15988674 [No Abstract] [Full Text] [Related]
38. [ACE inhibitor therapy until end of life?]. Werner N Dtsch Med Wochenschr; 2004 Oct; 129(44):2375-6. PubMed ID: 15497110 [No Abstract] [Full Text] [Related]
39. Antioxidants: not for prevention. Prescrire Int; 2009 Feb; 18(99):34. PubMed ID: 19391300 [TBL] [Abstract][Full Text] [Related]
40. Prevention of atherosclerosis. The potential role of antioxidants. Mehra MR; Lavie CJ; Ventura HO; Milani RV Postgrad Med; 1995 Jul; 98(1):175-6, 179-84. PubMed ID: 7603945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]